How the research library is built.

Automated discovery expands coverage. Source verification and editorial review determine what the site is willing to claim.

Collection

Records may be collected from PubMed, Europe PMC, ClinicalTrials.gov, regulatory documents and original publisher pages. Automated collection creates candidates. It does not establish that a study supports a compound, outcome or health claim.

Source verification

A summary requires a traceable primary record such as a PMID, DOI, trial registration, regulator document or publisher page. Records with missing, conflicting or changed citations remain blocked until resolved.

Evidence labels

Human, animal, cell or tissue, review, preprint and registry labels describe the source model. They are not grades of effectiveness. Registered trials describe planned or ongoing research and do not establish results.

Summaries and appraisal

Study summaries explain what was studied, the population or model, main findings and stated limitations. Abstract-based and full-text reviews are identified separately. A summary is not a formal quality appraisal.

Research priority

The review queue considers source availability, study design, human or translational relevance, recency, peptide relevance and scholarly attention. Citations and publication attention help order work, but they are not evidence of quality, safety or effectiveness.

Archive limitations

Search coverage is incomplete and evolves over time. Publication counts can include mentions, protocols and reviews, and should not be interpreted as independent trials or proof that one compound works better than another.